Literature DB >> 27208538

The revised 2014 FIGO staging system for epithelial ovarian cancer: Is a subclassification into FIGO stage IVA and IVB justified?

Beyhan Ataseven1, Philipp Harter2, Christoph Grimm3, Florian Heitz2, Sebastian Heikaus4, Alexander Traut2, Annett Kahl2, Christian Kurzeder2, Sonia Prader2, Andreas du Bois2.   

Abstract

OBJECTIVE: The revised 2014 FIGO staging system for epithelial ovarian cancer (EOC) included many changes of the previous system, particularly dividing FIGO stage IV in two subgroups. We evaluated if classifying patients with EOC in FIGO stage IVA and IVB has any prognostic implication.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  New FIGO classification; Overall survival; Stage IV epithelial ovarian cancer

Mesh：

Year:  2016        PMID： 27208538     DOI： 10.1016/j.ygyno.2016.05.021

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN： 0090-8258            Impact factor:   5.482


  7 in total

1.  Body weight changes in patients undergoing chemotherapy for ovarian cancer influence progression-free and overall survival.

Authors:  Marcin Mardas; Marta Stelmach-Mardas; Radosław Madry
Journal:  Support Care Cancer       Date:  2016-10-22       Impact factor: 3.603

2.  A novel nomogram based on LODDS to predict the prognosis of epithelial ovarian cancer.

Authors:  Xue-Lian Xu; Hao Cheng; Meng-Si Tang; Hai-Liang Zhang; Rui-Yan Wu; Yan Yu; Xuan Li; Xiu-Min Wang; Jia Mai; Chen-Lu Yang; Lin Jiao; Zhi-Ling Li; Zhen-Mei Zhong; Rong Deng; Jun-Dong Li; Xiao-Feng Zhu
Journal:  Oncotarget       Date:  2017-01-31

3.  A Prognostic Nomogram for Cervical Cancer after Surgery from SEER Database.

Authors:  Ce Wang; Chunyan Yang; Wenjie Wang; Bairong Xia; Kang Li; Fengyu Sun; Yan Hou
Journal:  J Cancer       Date:  2018-10-10       Impact factor: 4.207

4.  Impact of the new FIGO 2013 classification on prognosis of stage I epithelial ovarian cancers.

Authors:  Céline Montavon Sartorius; Uzma Mirza; Andreas Schötzau; Gillian Mackay; Daniel Fink; Neville F Hacker; Viola Heinzelmann-Schwarz
Journal:  Cancer Manag Res       Date:  2018-10-17       Impact factor: 3.989

5.  Isolated distant lymph node metastases in ovarian cancer. Should a new substage be created?

Authors:  Dimitrios Nasioudis; Emily M Ko; Ashley F Haggerty; Robert L Giuntoli; Robert A Burger; Mark A Morgan; Nawar A Latif
Journal:  Gynecol Oncol Rep       Date:  2019-03-13

6.  A retrospective study for investigating the relationship between old and new staging systems with prognosis in ovarian cancer using gynecologic cancer registry of Japan Society of Obstetrics and Gynecology (JSOG): disparity between serous carcinoma and clear cell carcinoma.

Authors:  Wataru Yamagami; Satoru Nagase; Fumiaki Takahashi; Kazuhiko Ino; Toru Hachisuga; Mikio Mikami; Takayuki Enomoto; Hidetaka Katabuchi; Daisuke Aoki
Journal:  J Gynecol Oncol       Date:  2020-01-13       Impact factor: 4.401

7.  Elevated Interleukin-6 Levels in the Circulation and Peritoneal Fluid of Patients with Ovarian Cancer as a Potential Diagnostic Biomarker: A Systematic Review and Meta-Analysis.

Authors:  Hina Amer; Apriliana E R Kartikasari; Magdalena Plebanski
Journal:  J Pers Med       Date:  2021-12-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.